Easily Send & Share Press Releases

(800) 307-6627
About Contact Us
Register Sign In
Tap to Toggle Navigation Menu
  • Newsroom
  • Pricing
  • Send Releases
    • Self Service Publishing
    • Full Service Publishing
    • Distribution Options
    • Reporting & Analysis
    • Search Engine Optimization
  • Send Releases
  • Regulatory Filings
  • NASDAQ OMX Media Suite
  • Learning & Support
    • Reader Support
    • Customer Support
    • Knowledge Base Archives
  • Learning & Support
Search Results

Organization: (Harris & Harris Group, Inc. OR Harris & Harris Group)

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Harris & Harris Group, Inc.
Harris & Harris Group

Narrow by:

Organization
Industry
  • Show Top 5

Subject
  • Show All

  • Show Top 5

Tag
  • Show More

  • Show Top 5

Date Published





Language
  • Show Top 5

Country
  • Show Top 5

State/Province
  • Show Top 5

Showing 1-10 of about 132 articles.

  • 1
  • 2
  • ...
  • 14
  • Next »

Harris & Harris Group

Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer

NEW YORK, May 16, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative companies, notes today's announcement by D-Wave Systems that its new 512-qubit quantum computer, the D-Wave Two, will be installed at the new Quantum Artificial Intelligence Lab, a collaboration among NASA, Google and the Universities Space Research Association (USRA). The purpose of this effort is to use quantum computing to advance machine learning in order to solve some of the most challenging computer science problems. A copy of D-Wave's press release can be viewed at

about 1 day ago 

Harris & Harris Group

Harris & Harris Group Reports Financial Statements as of March 31, 2013

NEW YORK, May 10, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), reported today that, as of March 31, 2013, its net asset value and net asset value per share were $127,749,103 and $4.11, respectively.

about 7 days ago 

Harris & Harris Group

Harris & Harris Group Notes Bridgelux and Toshiba Collaboration

NEW YORK, April 23, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative companies, notes today's announcement by Bridgelux, Inc., and Toshiba Corporation that they have entered into an agreement under which Bridgelux will sell to Toshiba its industry-leading GaN-on-Silicon technology and related assets, and the companies will strengthen and extend their strategic technology collaboration through an expanded licensing and manufacturing relationship.

about 24 days ago 

Harris & Harris Group

Harris & Harris Group to Webcast 2013 Annual Meeting of Shareholders

NEW YORK, April 19, 2013 (GLOBE NEWSWIRE) -- The management of Harris & Harris Group, Inc., (Nasdaq:TINY), will webcast its Annual Meeting of Shareholders live, to be held in New York City on Thursday, May 2, 2013. The webcast will include the official business of the meeting, to be followed by a brief presentation by Harris & Harris Group's management team to update shareholders on its business. The presentation portion of the webcast will begin at approximately 4:15 p.m. (EDT).

about 28 days ago 

Harris & Harris Group

Harris & Harris Group Announces New Investment in AgBiome

NEW YORK, April 11, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative companies, is pleased to announce its investment in AgBiome, LLC, as part of a $14.5 million Series A financing. The funds will further advance the company's research and development programs and support the launch of its first products. Polaris Partners led the round and was joined by ARCH Venture Partners, Harris & Harris Group, Innotech Advisers and additional strategic investors.  AgBiome's press release may be viewed at

about 36 days ago 

Harris & Harris Group

Harris & Harris Group Notes Article in The New York Times

NEW YORK, March 22, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative nanotechnology companies, notes an article by Quentin Hardy in the March 22, 2013, issue of

about 56 days ago 

Harris & Harris Group

Harris & Harris Group Reports Financial Statements as of December 31, 2012 and Posts Annual Letter to Shareholders on Website

NEW YORK, March 15, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), reported today that, as of December 31, 2012, its net asset value and net asset value per share were $128,436,774 and $4.13, respectively. The Company's Annual Report on Form 10-K may be accessed at http://ir.hhvc.com/sec.cfm.

about 63 days ago 

Harris & Harris Group

Harris & Harris Group to Host Conference Call on Fourth-Quarter 2012 Financial Results on March 20, 2013

NEW YORK, Feb. 13, 2013 (GLOBE NEWSWIRE) -- The management of Harris & Harris Group, Inc. (Nasdaq:TINY) will hold a conference call to discuss the Company's financial results for its fourth quarter 2012, to update shareholders and analysts on our business and to answer questions, on Wednesday, March 20, 2013, at 10:00 a.m. Eastern Time.

about 93 days ago 

Harris & Harris Group

Harris & Harris Group Notes Solazyme and Mitsui Multi-Year Agreement

NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative nanotechnology companies, notes that Solazyme, Inc., and Mitsui & Co. have entered into a $20 million multi-year agreement to jointly develop a suite of triglyceride oils for use primarily in the oleochemical industry. The agreement includes further development of Solazyme's high myristic algal oil, a valuable raw material in the oleochemical industry, as well as additional oils that Solazyme is developing for the oleochemical and industrial sectors. Product development is expected to span a multi-year period, with periodic product introductions throughout the term of the joint development alliance.  End-use applications may include renewable, high-performance polymer additives for plastic applications, aviation lubricants, and toiletry and household products. Solazyme's press release can be viewed at

about 99 days ago 

Harris & Harris Group

Harris & Harris Group Notes Announcement by Champions Oncology of $9.3 Million Raise

NEW YORK, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative nanotechnology companies, notes the announcement by Champions Oncology, Inc. that it raised $9.3 million in a private placement to existing and new investors at $0.50 per share. The investors were Battery Ventures IX, L.P., PAR Investment Partners, L.P., Harris & Harris Group, Inc., and members of the Company's management team. Harris & Harris Group invested $200,000 in the financing. Proceeds from the financing will be used to grow the TumorGraft™ bank to support the current Translational Oncology Solutions business and future biomarker development efforts, continue to build the senior management team, initiate a validation study for the Personalized Oncology Solutions business and general corporate purposes.  Champions' press release may be viewed at

about 106 days ago 

Showing 1-10 of about 132 articles.

  • 1
  • 2
  • ...
  • 14
  • Next »
Easily Send & Share Press Releases
  • Home
  • Newsroom
  • RSS Feeds
  • Send Releases
  • Regulatory Filings
  • Privacy Policy
© 2013 GlobeNewswire, Inc. All Rights Reserved.
About Us
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Contact Us
Corporate Headquarters
5200 W. Century Blvd.
Suite 890
Los Angeles, CA 90045
Phone: (800) 307-6627
Fax: (800) 307-3567
European Headquarters
Nikolaj Plads 6
P.O. Box 1040
Copenhagen, Denmark
Phone: +45 33 77 03 77
Fax: +45 33 12 86 13